Solutions
keyboard_arrow_downServices
keyboard_arrow_downSupport & Resources
keyboard_arrow_downCompany
keyboard_arrow_downContact
The RIQAS Point of Care International Normalised Ratio (INR) EQA programme is designed to measure the effect of anticoagulant drugs such as warfarin as well as helping to diagnose a bleeding disorder, helping to estimate the severity of liver disease. This bi-monthly EQA programme will ensure early identification of system errors and implementation of any necessary corrective actions with minimum disruption.
Cycle Starts: Feburary
Ready-to-use
Samples supplied ready-to-use, ensuring user convenience and no preparation before analysis.
Online User Portal
Easy to use interface for programme registration, result submission and retrieval of reports.
Multiple Instruments
Register up to 3 instruments per sample with no extra charge.
Get in touch to discover more
To find out more about RIQAS POC EQA or to get in touch with your local Randox Representative, enquire now.
| Cat No | Kit Size | Frequency | ||
|---|---|---|---|---|
| RQ9189 | 1 x 300µl | Bi-Monthly | Enrolment DocumentEnquire | |
| Tests | Roles | Matrix |
|---|---|---|
| International Normalised Ratio (INR) | Used to measure the effect of anticoagulant drugs such as warfarin Help diagnose a bleeding disorder; to help estimate the severity of liver disease | Whole Blood |
Please note, product availability may vary country to country.
RIQAS
The largest international EQA Scheme with over 76,000 Laboratory Participants.
